Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells.
about
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuGenetically modified T cells in cancer therapy: opportunities and challengesImmunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapiesHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferAn efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaAdoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma modelT cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID miceAdoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015.Improving TCR Gene Therapy for Treatment of Haematological Malignancies.A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy.Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansionThe past, present, and future of adoptive T cell therapy.A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells.Understanding and harnessing the graft-versus-leukaemia effect.Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008.Domain-swapped T cell receptors improve the safety of TCR gene therapy.Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia.Molecular immunology lessons from therapeutic T-cell receptor gene transfer.Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer.Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".Immunotherapy with gene-modified T cells: limiting side effects provides new challenges.Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors.Adoptive immunotherapy for cancer or viruses.Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptorsCytomegalovirus-specific T-cell therapies: current status and future prospects.Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.TCR-engineered T cells: a model of inducible TCR expression to dissect the interrelationship between two TCRsHuman MHC Class I-restricted high avidity CD4+ T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.Influenza virus-specific TCR-transduced T cells as a model for adoptive immunotherapy.Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.Adoptive cell transfer of T-cell receptor-engineered lymphocytes: lessons from recent modeling.Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.
P2860
Q21131200-05108337-3A5D-4B84-B9E8-77302CE81814Q27026627-528D532A-DD2B-4E37-8F45-40CD7FA287D5Q27027243-660969DC-979C-4F27-B6B3-40A93C03DBE7Q28727481-44D213C9-EEC4-4976-B32A-1368BAA4C178Q28749871-66D3B419-649B-4D70-A937-AF530B8A2EAFQ30437670-16F6E7AF-8891-41FD-9B7E-51890B6B03B2Q33530527-CEB08025-6912-48B9-A17B-F7EA2267819AQ33587590-C3FF325D-F18A-4A23-8E80-0C189BFF0895Q35641721-14E7C80A-A9A6-472D-B123-DF41ACF73A87Q35738738-2D27A9D6-B658-415F-B6F6-C538F9D0A27FQ36043637-0B3E10F1-B9EF-45B4-8B5C-188A2427FDC6Q36215613-661722C4-7B50-490A-9DD9-E05389C030A0Q36306644-621C3C25-4E00-46FA-9CC7-3D77B5946FC3Q36943923-4019AB45-61AA-4508-A62E-243B3126BCA7Q37194977-946BAF69-A60A-4B70-BFC6-BAADA1D7316BQ37216330-172C13F9-3CD9-4BE4-876D-076A6BB383D0Q37384350-B5F2A43C-5589-4856-BD67-8AC7D6E7D3DDQ37401728-6342270F-777E-42EE-9B7D-6C2A7254B6D6Q37747066-0C5B51B5-E954-4A53-87C7-4870A8D7028CQ37766303-728045B1-99F1-4A49-8233-B27C4CE92347Q37854072-F5C7493E-842A-4C1E-9BB2-B93882E9E011Q37919880-09A24221-FA00-4671-8334-BF4304F0B7E0Q38117268-3175D3B7-A5F8-4C25-BE63-89A085C013FBQ38172451-27469217-5CBE-4DB4-951E-1452EC442E19Q38178359-71D403ED-31DF-4FAE-84CF-7B57978FEF59Q38291751-DA784A89-0A66-4619-AB29-B5D474E0D5B6Q38365044-E31668D6-27A8-438D-9E44-3577DAF7CC2DQ39507137-076E6295-4E18-4A9C-9112-DFC6D2A064BFQ41069577-786FAFF2-DFA1-46F8-A0FD-015970889363Q41837100-8712B220-FBB3-4F95-820C-EC1683B73EC0Q43238571-BF90E7DA-E92C-4B04-945A-3D524BCA1173Q43964931-F6ADE6EA-266B-40C1-8495-3944A7C684B9Q45857062-8FB87304-5BF2-4DA8-8EF7-3577EBF31267Q51773657-BCCF1ADB-2DB5-4BED-8610-D7835B2DAB23Q51809142-F5DC78D7-C461-4CAE-BA83-B14D54D09E6F
P2860
Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Targeting the Wilms tumor anti ...... f gene modified human T cells.
@en
Targeting the Wilms tumor anti ...... f gene modified human T cells.
@nl
type
label
Targeting the Wilms tumor anti ...... f gene modified human T cells.
@en
Targeting the Wilms tumor anti ...... f gene modified human T cells.
@nl
prefLabel
Targeting the Wilms tumor anti ...... f gene modified human T cells.
@en
Targeting the Wilms tumor anti ...... f gene modified human T cells.
@nl
P2093
P1476
Targeting the Wilms tumor anti ...... of gene modified human T cells
@en
P2093
Balbino Alarcon
Daniel P Hart
Emma Morris
Hans J Stauss
Michela Cesco-Gaspere
Reno Debets
Shao-An Xue
Sharyn Thomas
Vivian Wong
P304
P356
10.4049/JIMMUNOL.179.9.5803
P407
P50
P577
2007-11-01T00:00:00Z